NIH VideoCast | October 15, 2020: SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Dr. Kizzmekia Corbett of the National Institute of Allergy and Infectious Diseases explains how she worked with the VRC to develop the vaccine prototype.
Read more about how NIAID had prepared for years to be able to shorten the time it takes to develop a vaccine.
Learn about NIAID’s extensive and ongoing coronavirus research.
Learn how the body fights infection and how COVID-19 vaccines protect people by producing immunity. Also see the different types of COVID-19 vaccines that currently are available or are undergoing large-scale (Phase 3) clinical trials in the United States.
Information about mRNA vaccines generally and COVID-19 vaccines that use this new technology specifically.
Information about viral vector vaccines generally and COVID-19 vaccines that use this new technology specifically.